Top Markets
Coin of the day
Lipum AB (publ) Lipum AB (publ)

Lipum AB (publ)

LIPUM
Clasificación en acciones #27261
Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on... Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on pioneering the discovery and development of therapeutic solutions for long-term inflammatory conditions. The company's primary therapeutic asset, SOL-116, is a humanized antibody currently in the late preclinical stage, designed to treat pediatric rheumatism and adult rheumatoid arthritis. To facilitate the advancement of SOL-116 into clinical trials, Lipum has established a collaboration with Pelago Bioscience AB to meticulously monitor drug targets. Founded in 2010, the company's operations are headquartered in Umeå, Sweden.
Precio por acción
$1.60
Última sincronización: 2026-03-18
Capitalización bursátil
$34.00M
Cambio (1 día)
0.70%
Cambio (1 año)
2.50%
País
SE
Comercio Lipum AB (publ) (LIPUM)

Categoría

Ratio P/B de Lipum AB (publ) (LIPUM)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Lipum AB (publ), el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Lipum AB (publ) desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH